{
  "company": "LUPIN",
  "report_date": "May 19, 2016",
  "filename": "LUPIN_transcript_Jun_2016.pdf",
  "quarter": "Q1",
  "fiscal_year": "2017",
  "management_team": [
    "MS. VINITA GUPTA - GROUP PRESIDENT & CHIEF",
    "MR. NILESH GUPTA - GROUP PRESIDENT & MANAGING",
    "MR. RAMESH SWAMINATHAN - CHIEF FINANCIAL",
    "MR. ALPESH DALAL - HEAD, M&A & IR LUPIN LIMITED",
    "MR. SHAKTI CHAKRABORTY - IN-CHARGE HEAD, INDIA",
    "MR. RAJEEV SIBAL - PRESIDENT, INDIA REGION",
    "MS. SOFIA MUMTAZ - PRESIDENT, IPMG, LUPIN",
    "DR. RAJENDER KAMBOJ - PRESIDENT, NOVEL DRUG",
    "MR. PAUL \nMCGARTY - PRESIDENT,",
    "VINITA GUPTA - GROUP PRESIDENT & CHIEF",
    "NILESH GUPTA - GROUP PRESIDENT & MANAGING",
    "RAMESH SWAMINATHAN - CHIEF FINANCIAL",
    "ALPESH DALAL - HEAD, M&A & IR LUPIN LIMITED",
    "SHAKTI CHAKRABORTY - IN-CHARGE HEAD, INDIA",
    "RAJEEV SIBAL - PRESIDENT, INDIA REGION",
    "SOFIA MUMTAZ - PRESIDENT, IPMG, LUPIN",
    "RAJENDER KAMBOJ - PRESIDENT, NOVEL DRUG",
    "PAUL \nMCGARTY - PRESIDENT,"
  ],
  "moderator": "Thank you",
  "analysts": [
    {
      "name": "Sangam Iyer",
      "firm": "Subhkam Ventures"
    }
  ],
  "qa_segments": [],
  "key_financial_metrics": {
    "growth_percentage": "32",
    "ebitda_margin_percentage": "34"
  },
  "business_highlights": [
    "launched about 19 products last year.",
    "launched in the last year, the products that we have acquired and there \nis opportunity on the Brand side of the business that we leverage out of the Gavis \nportfolio and new products additions out of India as well as of Somerset.",
    "acquired the 40% remaining equity from the erstwhile \npromoter, we have acquired a business in Brazil Medquimica, we have acquired \nGavis which is our largest acquisition and one of the largest out of India, we also \nacquired a small CNS portfolio in Germany called Temmler.",
    "acquired in October 2007 has registered a compounded annual growth rate of 16% \non constant foreign exchange.",
    "acquired has also \nbeen producing results and growing at a very healthy clip.",
    "acquired a R&D facility in Netherlands in the name of Nanomi and \nbetween LRP, that is Pune facility and Nanomi, will be developing a set of Complex \nInjectables.",
    "acquired a company Temmler which adds to the CNS portfolio of  \nGermany.",
    "acquired and there \nis opportunity on the Brand side of the business that we leverage out of the Gavis \nportfolio and new products additions out of India as well as of Somerset.",
    "acquired Gavis for about $890 million and bulk of the debt that you see on the \nbalance sheet is actually going towards its outlay."
  ],
  "extraction_metadata": {
    "extraction_date": "2025-08-03T01:08:57.935686",
    "source_file": "data\\lupin\\LUPIN_transcript_Jun_2016.pdf",
    "text_length": 66287,
    "extraction_method": "PyMuPDF + Regex parsing + Filename analysis"
  }
}